Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-14

Clinical Trial Update: Time-dependent Amiodarone Treatment in Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on time-dependent amiodarone treatment for atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)

Snippet

Sponsor: Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED